Kamada’s KamRAB Meets Primary Endpoint January 6, 2016 The therapy is designed for the treatment of rabies. Read More
Chimerix’s Brincidofovir Flops in Phase 3 Study January 5, 2016 The oral compound failed to prevent cytomegalovirus infection through week 24 following blood and marrow transplants. Read More
Adamas Levodopa-Induced Dyskinesia Candidate Reaches Primary Endpoint in Study January 4, 2016 Patients receiving ADS-5102 showed a 23 percent reduction in LID compared with placebo. Read More
Merck KGaA, Pfizer Advance Phase 3 Trials of Avelumab December 30, 2015 The candidate is for the treatment for patients with bladder cancer. Read More
Pfizer’s Depression Candidate Flops in Phase 3 Study December 30, 2015 The candidate failed to meet its primary objective of superiority versus placebo. Read More
Baxalta Therapies Meet Primary Endpoints December 29, 2015 A proposed Humira biosimilar, as well as Adynovate, met its primary endpoint. Read More
Array BioPharma’s Melanoma Candidate Meets Primary Endpoint December 22, 2015 Median PFS on the binimetinib arm was 2.8 months versus 1.5 months on comparator dacarbazine. Read More
FDA Removes Clinical Hold on Advaxis IND Applications December 22, 2015 Advaxis may resume clinical studies with axalimogene filolisbac, ADXS-PSA and ADXS-HER2. Read More
Kitov Reports Positive Results in Phase 3 Trial for Osteoarthritis Candidate December 21, 2015 KIT-302 was more effective at reducing hypertension than amlodipine besylate alone. Read More
Atara to Suspend Development of Protein Energy Wasting Treatment December 18, 2015 Atara says it will shift its focus to its portfolio of clinical stage oncology and immunotherapy product candidates. Read More
Report Finds Drugmakers Not Getting Bang for Buck in R&D Spending December 18, 2015 The report found that larger companies spent more on R&D this year and will see the lowest return since 2010. Read More
BIO, Duchenne Advocates Team Up to Design Studies With Patient Input December 16, 2015 The alliance aims to collect real-world “community-centered” snapshots that hone in on desired patient outcomes. Read More